Seeking Alpha

XOMA Ltd (XOMA)

()

News & PR
Market Currents

Buzz
Twitter: XOMA

Business Intelligence
Transcripts
Events
Key Developments

Instablog posts on XOMA

Graft Versus Host Disease: Failures and Future Opportunities by Michael Becker
In September 2009, Osiris Therapeutics, Inc. (OSIR) reported preliminary results from two Phase III trials evaluating its Prochymal product candidate for the treatment of acute Graft-versus-Host disease [GVHD]. Unfortunately, neither trial reached its primary endpoint, sending shares from... More »
December 9, 2009 • OSIR, CYCC, XOMA
XOMA (XOMA): WHAT DO WE NEED FROM THIS FIRM? by Prohost Biotech
Xoma signed a collaboration agreement with Arana Therapeutics Limited, a wholly owned subsidiary of Cephalon (CEPH). The agreement involves multiple proprietary antibody research and development technologies, including a new antibody phage display library, and a suite of integrated information... More »
September 21, 2009 • XOMA
Novel Diabetes Therapies Presented at the 2009 ADA Meeting by Michael Becker
By Jeffrey Martini, PhD.Approximately 250 million people worldwide have been diagnosed with diabetes mellitus and that number is growing with the increasing obesity population. Broadly, patients with diabetes are characterized by elevated blood glucose levels that result from either... More »
June 23, 2009 • LLY, SNY, NVO
MD Becker Partners' biotechnology sector movers - closing report by Michael Becker
Today's biotechnology companies that outperformed the broader market on greater than average volume (3-month) as of the market close: AEZS, ARNA, CTIC, CYCC, FOLD, MHAN.OB, SPPI, SVNT, XOMA
June 15, 2009 • AEZS, ARNA, CTIC
FDA, Clinical Trial Calendars: Prevacid Goes OTC, Swine Flu Test by Mike Havrilla
Below is a summary of updates to the BioMedReports.com database of over 200 entries included in the FDA and Clinical Trial Calendars. The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA decision... More »
May 14, 2009 • XOMA, CADX, ALTH

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

XOMA Ltd (XOMA)

Instablog posts on XOMA

Graft Versus Host Disease: Failures and Future Opportunities by Michael Becker

XOMA (XOMA): WHAT DO WE NEED FROM THIS FIRM? by Prohost Biotech

Novel Diabetes Therapies Presented at the 2009 ADA Meeting by Michael Becker

MD Becker Partners' biotechnology sector movers - closing report by Michael Becker

FDA, Clinical Trial Calendars: Prevacid Goes OTC, Swine Flu Test by Mike Havrilla

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers